Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is Ablation of All Inducible Atrial Tachycardias an Appropriate Endpoint During Redo Procedures After Initial Persistent AF Ablation? A Multi-center, Randomised, Single-blind Study

NCT03343860 is registered in ClinicalTrials.gov with AZ Sint-Jan AV as lead sponsor.

NCT NCT03343860
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03343860 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is Ablation of All Inducible Atrial Tachycardias an Appropriate Endpoint During Redo Procedures After Initial Persistent AF Ablation? A Multi-center, Randomised, Single-blind Study
Lead sponsor
AZ Sint-Jan AV
Phase
Not applicable
Overall status
Completed
Start date
April 5, 2017
Completion date
May 31, 2022
Enrollment
60 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, atrial tachycardia